Nutex Health Inc.
NUTX
$131.90
-$3.58-2.64%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 42.73% | -43.36% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 42.73% | -43.36% | |||
| Cost of Revenue | 27.07% | -13.03% | |||
| Gross Profit | 68.13% | -63.83% | |||
| SG&A Expenses | 110.98% | -488.68% | |||
| Depreciation & Amortization | 5.88% | 3.68% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3,495.32% | -97.26% | |||
| Operating Income | -45.06% | 13.46% | |||
| Income Before Tax | 195.67% | -79.11% | |||
| Income Tax Expenses | 48.58% | -65.78% | |||
| Earnings from Continuing Operations | 277.91% | -82.84% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -234.23% | 88.46% | |||
| Net Income | 295.53% | -78.65% | |||
| EBIT | -45.06% | 13.46% | |||
| EBITDA | -43.33% | 13.10% | |||
| EPS Basic | 300.12% | -79.77% | |||
| Normalized Basic EPS | -61.83% | 121.94% | |||
| EPS Diluted | 316.67% | -79.84% | |||
| Normalized Diluted EPS | -62.84% | 137.71% | |||
| Average Basic Shares Outstanding | -1.15% | 5.52% | |||
| Average Diluted Shares Outstanding | 1.53% | -1.48% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||